NeoChemir Inc.

Chūō-ku, Japan

NeoChemir Inc.

Chūō-ku, Japan

Time filter

Source Type

Patent
Neochemir Inc., Kobe University and Co2Be Medical Engineering K.K. | Date: 2013-09-25

A liquid medicine of the present invention comprising liquid having carbon dioxide dissolved therein, said liquid being administered by using means of liquid injection, and a method of treatment of the present invention using a liquid medicine comprising liquid having carbon dioxide dissolved therein, said liquid being administered by using means of liquid injection can reduce or eliminate tumors with few side effects. When the liquid medicine of the present invention comprising liquid having carbon dioxide dissolved therein, said liquid being administered by using means of liquid injection, and the method of treatment of the present invention using a liquid medicine comprising liquid having carbon dioxide dissolved therein, said liquid being administered by using means of liquid injection are used in combination with surgical therapy, chemotherapy, radiotherapy, or immunotherapy of tumors, effects can be enhanced or side effects can be reduced compared with monotherapy or multidisciplinary therapy thereof.


Patent
Neochemir Inc. | Date: 2014-06-19

A carbon dioxide administering apparatus to administer carbon dioxide to a part of the human skin that has an almost sealed Space (210) in which legs can be placed, Solvent tank (8) that reserves vaporable Solvent (8) in which carbon dioxide dissolves at the bottom of Space (210), Heating part (22) that heats up Solvent (8) in Solvent tank (23) to vaporize, Carbon dioxide supplying part (24) that supplies carbon dioxide into Space (210) above Solvent tank (23), and Adhesion part (25), to which floating droplets produced from Solvent (8) in Solvent tank (23) adhere, placed in Space (210) above Solvent tank (23). Legs can be placed in Space (210) above Adhesion part (25).


The present invention provides a prophylactic or therapeutic agent for fracture and bone diseases as well as a bone growth promoting agent containing carbon dioxide as an active ingredient. Further, according to the present invention, an additive or synergistic effect for preventing or treating fracture and bone diseases as well as for promoting bone growth by combining the therapeutic agent of the present invention and a bone absorption inhibitor and/or a bone formation promoter is obtained.


An acidic composition for external use which contains an acidic polysaccharide and water as essential ingredients, and an agent for accelerating the penetration into skin or the like of a cosmetic preparation, hair-growing agent or preparation for external use, each containing the composition. The composition is easy to manufacture, and shows a stronger cosmetic or therapeutic effects than conventional compositions.


An apparatus for preparing a gas for transdermal absorption is provided with: a carbon dioxide supplying unit (1) that supplies gaseous carbon dioxide; a solvent vapor generating unit (2) that generates vapor of a solvent (20), being capable of dissolving the carbon dioxide and vaporable; and a generating unit of a gas for transdermal absorption that generates a gas for transdermal absorption containing the gaseous carbon dioxide-solvent complex by mixing the supplied carbon dioxide and the generated solvent vapor, and is characterized by being further provided with a floating liquid drop removing unit (4) that removes a floating liquid drop of the solvent (20) from the generated gas for transdermal absorption.


An apparatus for preparing a gas for transdermal absorption is provided with: a carbon dioxide supplying unit (1) that supplies gaseous carbon dioxide; a solvent vapor generating unit (2) that generates vapor of a solvent (20), being capable of dissolving the carbon dioxide and vaporable; and a generating unit of a gas for transdermal absorption that generates a gas for transdermal absorption containing the gaseous carbon dioxide-solvent complex by mixing the supplied carbon dioxide and the generated solvent vapor, and is characterized by being further provided with a floating liquid drop removing unit (4) that removes a floating liquid drop of the solvent (20) from the generated gas for transdermal absorption.


Patent
Neochemir Inc., CO2BE Medical Engineering K.K. and Kobe University | Date: 2014-02-05

An antitumor agent comprising carbon dioxide as an active ingredient of the present invention can reduce the tumor volume or eradicate the tumor of a patient who is difficult to take a surgical therapy, a chemotherapy, a radiation therapy or an immunotherapy. The antitumor agent comprising carbon dioxide as an active ingredient of the present invention is useful because the agent enables (1) the reduction in size or elimination of a tumor, (2) the suppression of tumor metastasis and also (3) the reduction in volume or elimination of a tumor at a part different from the part where carbon dioxide is transdermally absorbed by the transdermal absorption of carbon dioxide through the skin near the tumor or the skin far from the tumor. When the antitumor agent comprising carbon dioxide as an active ingredient of the present invention is used in combination with a surgical therapy, a chemotherapy, a radiation therapy or an immunotherapy, the effect can be potentiated or side effects can be reduced as compared with a monotherapy or a multidisciplinary therapy thereof


Patent
Neochemir Inc., CO2BE Medical Engineering K.K. and Kobe University | Date: 2015-08-05

A liquid medicine of the present invention comprising liquid having carbon dioxide dissolved therein, the liquid being administered by using means of liquid injection, and a method of treatment of the present invention using a liquid medicine comprising liquid having carbon dioxide dissolved therein, the liquid being administered by using means of liquid injection can reduce or eliminate tumors with few side effects. When the liquid medicine of the present invention comprising liquid having carbon dioxide dissolved therein, the liquid being administered by using means of liquid injection, and the method of treatment of the present invention using a liquid medicine comprising liquid having carbon dioxide dissolved therein, the liquid being administered by using means of liquid injection are used in combination with surgical therapy, chemotherapy, radiotherapy, or immunotherapy of tumors, effects can be enhanced or side effects can be reduced compared with monotherapy or multidisciplinary therapy thereof.


Patent
Neochemir Inc., Kobe University and Co2Be Medical Engineering K.K. | Date: 2012-03-22

An antitumor agent comprising carbon dioxide as an active ingredient of the present invention can reduce the tumor volume or eradicate the tumor of a patient who is difficult to take a surgical therapy, a chemotherapy, a radiation therapy or an immunotherapy. The antitumor agent comprising carbon dioxide as an active ingredient of the present invention is useful because the agent enables (1) the reduction in size or elimination of a tumor, (2) the suppression of tumor metastasis and also (3) the reduction in volume or elimination of a tumor at a part different from the part where carbon dioxide is transdermally absorbed by the transdermal absorption of carbon dioxide through the skin near the tumor or the skin far from the tumor. When the antitumor agent comprising carbon dioxide as an active ingredient of the present invention is used in combination with a surgical therapy, a chemotherapy, a radiation therapy or an immunotherapy, the effect can be potentiated or side effects can be reduced as compared with a monotherapy or a multidisciplinary therapy thereof.


Patent
Neochemir Inc., Kobe University and Co2Be Medical Engineering K.K. | Date: 2012-07-13

The present invention provides a prophylactic or therapeutic agent for fracture and bone diseases as well as a bone growth promoting agent containing carbon dioxide as an active ingredient. Further, according to the present invention, an additive or synergistic effect for preventing or treating fracture and bone diseases as well as for promoting bone growth by combining the therapeutic agent of the present invention and a bone absorption inhibitor and/or a bone formation promoter is obtained.

Loading NeoChemir Inc. collaborators
Loading NeoChemir Inc. collaborators